| Patients aged 14–17 years | Patients aged 18–24 years | ||
---|---|---|---|---|
 | T1D | T2D | T1D | T2D |
2016 | 4.4 (4.0–4.8) | 4.6 (1.3–8.0) | 7.9 (7.3–8.5) | 8.6 (5.6–11.6) |
2017 | 5.0 (4.6–5.4) | 8.9 (5.8–12.1) | 8.5 (7.9–9.1) | 10.1 (7.1–13.0) |
2018 | 4.8 (4.4–5.2) | 8.9 (5.7–12.1) | 8.9 (8.2–9.6) | 10.8 (8.0–13.6) |
2019 | 5.4 (5.0–5.8) | 4.6 (1.3–7.9) | 9.3 (8.5–10.2) | 11.6 (8.4–14.8) |
2020 | 5.5 (5.1–5.9) | 9.2 (6.2–12.1) | 10.4 (9.2–11.5) | 16.4 (13.1–19.7) |
2021 | 5.2 (4.7–5.6) | 7.3 (4.3–10.3) | 8.3 (7.1–9.5) | 15.0 (10.7–19.2) |
2022 | 5.2 (4.8–5.7) | 4.7 (1.9–7.6) | 9.8 (8.4–11.2) | 10.1 (4.2–15.9) |
2023 | 5.7 (5.2–6.1) | 6.3 (3.6–9.0) | 9.4 (8.0–10.9) | 7.7 (2.3–13.2) |